Anteris Technologies Finalizes $250M At-The-Market Offering, Enabling Immediate Share Sales
AVR has more than doubled off its 52-week low of $2.85.
Summary
Anteris Technologies Global Corp. has finalized its $250 million At-The-Market (ATM) equity offering, making the program operational for immediate share sales and potentially diluting existing shareholders by a substantial amount.
Key Events · Financing and Capital Events · AVR
-
$250 Million At-The-Market Offering Finalized
Anteris Technologies Global Corp. has finalized the terms for its At-The-Market (ATM) equity offering, allowing it to sell up to $250 million of common stock through TD Securities (USA) LLC. This filing makes the program operational for immediate share sales.
-
Significant Potential Dilution
The $250 million offering represents a substantial potential dilution for existing shareholders, equivalent to approximately 28.3% of the company's current market capitalization if fully utilized.
-
Proceeds for Development and Working Capital
Net proceeds from the offering are intended to fund the ongoing development of the DurAVR® Transcatheter Heart Valve System, as well as for general working capital purposes.
-
Follows Recent Capital Raises
This ATM offering follows the company's recent $320 million capital raise reported in Q1 2026 and the initial announcement of this $250 million ATM program on May 22, 2026, via an 8-K and 424B5 filing.
Analysis · AVR · Industrial Applications And Services
Anteris Technologies Global Corp. has finalized the terms of its previously announced At-The-Market (ATM) equity offering, allowing it to sell up to $250 million of common stock. This 424B3 prospectus supplement incorporates the 8-K filed on May 22, 2026, which established the sales agreement with TD Securities (USA) LLC. This filing makes the ATM program fully operational, enabling the company to begin selling shares into the market. The potential dilution from this offering is substantial, representing approximately 28.3% of the company's current market capitalization if fully utilized. While the capital is intended for product development and working capital, which are necessary for the company's operations, the significant potential dilution is a negative signal for existing shareholders.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 37.4% of the 3413 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AVR was trading at $9.08 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $883.9M. The 52-week trading range was $2.85 to $9.79. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.